Vaishali Pharma Q2 Results
- BSE: -
- NSE: VAISHALI
- ISIN: INE972X01022
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
11.81
0.38 (3.32%)
0.38 (3.32%)Volume7.34 L
Updated: Mon 7 Jul, 2025 | 15:45:41
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Vaishali Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 18.49 | 15.85 | 16.60% |
| Depreciation/ Amortization | 0.12 | 0.12 | 2.18% |
| Operating Income | 2.30 | 2.22 | 3.29% |
| Net Income | 1.97 | 1.70 | 15.85% |
| Other Operating Expenses Total | 0.94 | 0.66 | 43.04% |
| Net Income Before Taxes | 2.63 | 2.27 | 15.85% |
| Total Revenue | 20.79 | 18.08 | 14.97% |
| Selling/ General/ Admin Expenses Total | 0.62 | 0.59 | 6.15% |
| Diluted Normalized EPS | 1.51 | 0.14 | 994.20% |